Please login to the form below
financial intermediary fund
This page shows the latest financial intermediary fund news and features for those working in and with pharma, biotech and healthcare.
WHO, WIPO and WTO to hold technical symposium on pandemic preparedness
WHO also announced the official establishment of the new financial intermediary fund (FIF) for pandemic prevention, preparedness and response (PPR) by the FIF Governing Board in September. ... Over $1.4bn in financial commitments were announced at the
Latest news
-
WHO partners with IANPHI to strengthen health emergency preparedness
Last month, WHO announced the official establishment of the new financial intermediary fund (FIF) for pandemic prevention, preparedness and response (PPR) by the FIF Governing Board. ... Over $1.4bn in financial commitments were announced at the time of
-
WHO announces new global fund for pandemic prevention and preparedness
The World Health Organization (WHO) has announced the official establishment of the new financial intermediary fund (FIF) for pandemic prevention, preparedness and response (PPR) by the FIF Governing Board, with the ... We welcome the broad support from
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Future-proofing pharma supply chains by improving inefficiencies in global health architecture
Big pharma recently lobbied for a slice of the G20 fund to prepare for the next pandemic, leading to the establishment of a financial intermediary fund (FIF). ... This will help to take the financial sting out of the price of preparation.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Europe’s cancer community publishes new report on transforming patient care
- Eli Lilly announces $450m investment in US manufacturing site
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- ASH 2022: bad blood but big advances
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- MIT researchers develop AI model to detect future lung cancer risk
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Kite and Arcellx close multiple myeloma collaboration agreement
- The challenges of identifying rare diseases
- Live Webinar: Streamlining Healthcare Delivery Through Digital Care Journeys
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- Boehringer reports positive phase 2 data for spesolimab in generalised pustular psoriasis
- EU outlines measures to mitigate antibiotic shortage across Europe
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Europe’s cancer community publishes new report on transforming patient care
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- Boehringer reports positive phase 2 data for spesolimab in generalised pustular psoriasis
- EC launches cancer imaging initiative to accelerate innovation and early diagnosis
PMHub
Springer Nature
Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...
Latest intelligence
- The challenges of identifying rare diseases
- With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
- 5 ways we’re enhancing our services to support our clients in 2023
- Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
- ASH 2022: bad blood but big advances
- Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
